Prevalence of Multiple Sclerosis in Bogotá, Colombia

dc.contributor.authorJaime Toro
dc.contributor.authorOlga L. Sarmiento
dc.contributor.authorAdriana Díaz del Castillo
dc.contributor.authorClaudia L. Satizábal
dc.contributor.authorJhon Darwin Ramírez
dc.contributor.authorAna Cristina de Albuquerque Montenegro
dc.contributor.authorMaría Carolina Góngora
dc.contributor.authorJairo Quiñones
dc.contributor.authorAndrés Díaz-Campos
dc.contributor.authorAlejandro Tobón
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:05:24Z
dc.date.available2026-03-22T14:05:24Z
dc.date.issued2006
dc.descriptionCitaciones: 61
dc.description.abstractAmong Latin American countries, Colombia is considered a low-risk area for multiple sclerosis (MS) and no studies on MS prevalence have been conducted in any of the country's large urban settings. To fill this gap and assess the prevalence of MS in Bogotá as of December 31, 2002, this study reviewed the clinical records of patients diagnosed with MS in most Bogotá hospitals. This review produced a sample of 296 patients with an MS diagnosis whose reliability was verified by a neurologist with expertise in MS. The total prevalence rate identified for December 2002 was 4.41/100,000 inhabitants (95% CI 3.9-4.9), including a rate of 5.98/100,000 (95% CI 5.2-6.8) for women and 2.71/100,000 (95% CI 2.2-3.3) for men (differences measured at p < 0.001). The prevalence estimates for Bogotá, confirm the city's status as a low-risk area for MS.
dc.identifier.doi10.1159/000097854
dc.identifier.urihttps://doi.org/10.1159/000097854
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/44477
dc.language.isoen
dc.publisherKarger Publishers
dc.relation.ispartofNeuroepidemiology
dc.sourceFundación Santa Fe de Bogotá
dc.subjectMedicine
dc.subjectMultiple sclerosis
dc.subjectLatin Americans
dc.subjectEpidemiology
dc.subjectPrevalence
dc.subjectDemography
dc.subjectPediatrics
dc.titlePrevalence of Multiple Sclerosis in Bogotá, Colombia
dc.typearticle

Files